Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DGX

Quest Diagnostics, Inc

Feb 10 • 04:00PM ET

205.35

+14.10 7.37 %

Healthcare • Diagnostics & Research • USA • NYSE

Feb 10, 10:20 PMQuest Diagnostics posts Q4 and FY2025 results with strong organic growth and margin expansion, raises and details its 2026 outlook to $11.7–$11.82B revenue and $10.50–$10.70 EPS (including ~$0.25 EPS dilution from Project Nova) and highlights growth ramps from Corewell, Fresenius and QuestHealth; also hikes the quarterly dividend 7.5% to $0.86 and expands its share repurchase authorization by $1B.

Peers: LH NEO EXAS OPK NTRA PMD

| Held by: VTI VOO VO IVV SPY VTV RSP XLV VOE VIG

Scroll to Statements

Index	S&P 500	P/E	23.45	EPS (ttm)	8.76	Insider Own	0.46%	Shs Outstand	111.24M	Perf Week	10.90%
Market Cap	22.84B	Forward P/E	17.98	EPS next Y	11.42	Insider Trans	-16.75%	Shs Float	110.73M	Perf Month	17.72%
Enterprise Value	28.92B	PEG	2.20	EPS next Q	2.37	Inst Own	98.64%	Short Float	5.26%	Perf Quarter	14.40%
Income	988.00M	P/S	2.07	EPS this Y	7.13%	Inst Trans	-0.13%	Short Ratio	5.45	Perf Half Y	15.13%
Sales	11.04B	P/B	3.15	EPS next Y	8.23%	ROA	6.10%	Short Interest	5.82M	Perf YTD	18.34%
Book/sh	65.18	P/C	54.39	EPS next 5Y	8.19%	ROE	14.17%	52W High	197.55 3.95%	Perf Year	24.31%
Cash/sh	3.78	P/FCF	16.81	EPS past 3/5Y	3.11% -3.62%	ROIC	7.67%	52W Low	157.20 30.63%	Perf 3Y	41.82%
Dividend Est.	4.48 (2.18%)	EV/EBITDA	13.31	Sales past 3/5Y	3.74% 3.18%	Gross Margin	36.11%	Volatility	3.43% 2.37%	Perf 5Y	66.21%
Dividend TTM	3.20 (1.56%)	EV/Sales	2.62	EPS Y/Y TTM	13.81%	Oper. Margin	14.53%	ATR (14)	4.64	Perf 10Y	230.57%
Dividend Ex-Date	Apr 06, 2026	Quick Ratio	0.96	Sales Y/Y TTM	11.78%	Profit Margin	8.95%	RSI (14)	75.50	Recom	2.25
Dividend Gr. 3/5Y	6.62% 7.39%	Current Ratio	1.04	EPS Q/Q	11.97%	SMA20	9.78%	Beta	0.67	Target Price	216.57
Payout	36.57%	Debt/Eq	0.89	Sales Q/Q	7.06%	SMA50	12.74%	Rel Volume	2.17	Prev Close	191.25
Employees	56000	LT Debt/Eq	0.80	Earnings	Feb 10 BMO	SMA200	14.34%	Avg Volume	1.07M	Price	205.35
IPO	Dec 17, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.42% 1.88%	Trades		Volume	2,307,873	Change	7.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-30-26	Upgrade	Barclays	Equal Weight → Overweight	$210
Aug-25-25	Downgrade	Robert W. Baird	Outperform → Neutral	$194
Apr-02-25	Initiated	Redburn Atlantic	Buy	$195
Mar-04-25	Downgrade	Citigroup	Buy → Neutral	$185
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$169 → $174
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142

Show Previous Ratings

Feb-10-26 10:07PM	Quest Diagnostics Q4 Earnings Call Highlights (MarketBeat) +7.37%
05:45PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
05:08PM	Quest Diagnostics CEO: Chronic Care Disease Management a Big Driver (Bloomberg)
04:02PM	Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:30PM	Why Is Quest (DGX) Stock Soaring Today (StockStory)
02:54PM	Loading…
02:54PM	Stock Market Today: Dow Weakens After Hitting A High; Medical Name Breaks Out (Live Coverage) (Investor's Business Daily)
02:05PM	Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike (Benzinga)
10:43AM	Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up (Zacks)
09:50AM	Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock (Zacks)
07:55AM	Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update (RTT News)
07:06AM	Quest Diagnostics: Q4 Earnings Snapshot (Associated Press Finance)
06:58AM	Quest's (NYSE:DGX) Q4 CY2025: Beats On Revenue (StockStory)
06:47AM	Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share (PR Newswire)
06:33AM	Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization (PR Newswire)
02:08PM	Loading…
Feb-09-26 02:08PM	MedTech Stocks to Report Earnings on Feb. 10: DGX, ZBH & EW (Zacks)
Feb-08-26 10:04PM	Quest (DGX) Q4 Earnings: What To Expect (StockStory)
Feb-06-26 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
09:45AM	Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings (Zacks)
Feb-05-26 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Feb-04-26 09:40AM	Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-03-26 10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
Feb-02-26 08:52AM	Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease (PR Newswire)
Jan-30-26 09:54AM	Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
Jan-26-26 09:40AM	How TEM Is Capitalizing on AI-Driven Pathology Market Growth (Zacks)
Jan-21-26 02:35PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year (PR Newswire)
Jan-15-26 11:15PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
09:00AM	Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect (PR Newswire)
Jan-13-26 11:06PM	3 Reasons to Sell DGX and 1 Stock to Buy Instead (StockStory)
Jan-12-26 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
02:24PM	Loading…
Jan-09-26 02:24PM	Clinical Labs Hope to Head Off Looming Medicare Cuts (Barrons.com)
09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
10:00AM	Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 (PR Newswire)
08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 09:45AM	Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
07:25AM	IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? (Zacks)
Jan-06-26 10:01AM	Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
08:17AM	Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? (Zacks)
08:12AM	Should Labcorp Stock Stay in Your Portfolio Right Now? (Zacks)
Jan-05-26 08:58AM	Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan (PR Newswire)
06:51AM	What You Need To Know Ahead of Quest Diagnostics' Earnings Release (Barchart)
Jan-02-26 07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Jan-01-26 10:33PM	Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
Dec-30-25 12:00PM	Quest Diagnostics (DGX) Upgraded to Buy: Here's Why (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 09:40AM	Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-19-25 03:20PM	Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-18-25 07:14PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
07:54AM	How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? (Barchart)
Dec-17-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Dec-15-25 08:07AM	Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector? (Barchart)
Dec-12-25 09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Dec-03-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Dec-01-25 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
08:30AM	Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave Multiple Sclerosis Disease Activity (MSDA) Test Across the United States (Business Wire)
Nov-28-25 11:30AM	Why Is DaVita HealthCare (DVA) Up 1.1% Since Last Earnings Report? (Zacks)
Nov-27-25 11:30AM	Chemed (CHE) Down 5.2% Since Last Earnings Report: Can It Rebound? (Zacks)
08:23AM	HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? (Zacks)
Nov-26-25 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
Nov-24-25 07:53AM	Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? (Zacks)
Nov-20-25 11:30AM	Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue? (Zacks)
07:08AM	Quest Diagnostics Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Nov-17-25 08:55AM	How Did Tempus AI Power Its Move to Positive EBITDA in Q3? (Zacks)
Nov-14-25 06:16AM	Labcorp inks deal to buy Parkview Health outreach laboratory assets (MedTech Dive)
Nov-13-25 11:49AM	Hims & Hers Bets on Lab Testing to Boost Growth (The Wall Street Journal)
09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Nov-11-25 07:50PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
04:22PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
Nov-10-25 09:45AM	Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
Nov-03-25 04:09PM	Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference (PR Newswire)
Oct-29-25 07:09PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
Oct-27-25 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
07:45AM	New Study Demonstrates Accuracy of Two Quest AD-Detect Tests for Alzheimer's Disease Diagnosis (PR Newswire)
Oct-22-25 05:36PM	Quest Diagnostics Incorporated (DGX): A Bull Case Theory (Insider Monkey)
09:45AM	Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock (Zacks)
Oct-21-25 03:07PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
03:02PM	Quest Diagnostics Inc (DGX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:29AM	Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise (Zacks)
07:55AM	Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
06:59AM	Quest (NYSE:DGX) Posts Better-Than-Expected Sales In Q3 (StockStory)
06:52AM	Quest Diagnostics: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 (PR Newswire)
Oct-19-25 11:07PM	Quest (DGX) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-17-25 09:45AM	Tempus AI Fuels Growth Through Strategic Biotech Collaborations (Zacks)
02:53AM	MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD Technology from Quest Diagnostics (PR Newswire)
Oct-14-25 12:10PM	Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:00AM	Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:38AM	Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings (Zacks)
Oct-13-25 07:58AM	Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus (Zacks)
12:22AM	What to Expect From Quest Diagnostics Next Quarterly Earnings Report (Barchart)
Oct-09-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-03-25 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
Oct-01-25 10:17AM	Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing (Zacks)
08:00AM	Oura launches Ring 4 Ceramic collection, new charging case, and a health panel feature (TechCrunch)
Sep-30-25 09:05AM	DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute (Zacks)
08:00AM	Whoop opens blood-testing service to what it says is a 350,000-person waitlist (TechCrunch)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Plewman Patrick	Officer	Feb 10 '26	Proposed Sale	204.00	5,662	1,155,048		Feb 10 12:46 PM
Davis J. E.	CEO and President	Nov 25 '25	Option Exercise	95.80	55,093	5,277,634	175,573	Nov 28 04:30 PM
Davis J. E.	CEO and President	Nov 25 '25	Sale	192.22	55,093	10,589,760	120,480	Nov 28 04:30 PM
Gregg Vicky B	Director	Nov 25 '25	Sale	191.76	1,250	239,700	17,037	Nov 28 04:30 PM
Davis J. E.	Officer	Nov 25 '25	Proposed Sale	192.22	55,093	10,589,762		Nov 25 04:24 PM
Gregg Vicky B	Director	Nov 25 '25	Proposed Sale	191.76	1,250	239,700		Nov 25 09:42 AM
DELANEY MARK E	SVP & Chief Commercial Officer	Nov 18 '25	Option Exercise	144.46	7,946	1,147,845	15,476	Nov 20 04:28 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Nov 18 '25	Sale	187.35	7,946	1,488,683	7,530	Nov 20 04:28 PM
DELANEY MARK E	Officer	Nov 18 '25	Proposed Sale	187.35	7,946	1,488,683		Nov 18 11:02 AM
PFEIFFER GARY M	Director	Oct 22 '25	Sale	182.40	1,482	270,317	29,431	Oct 24 06:10 PM
PFEIFFER GARY M	Director	Oct 22 '25	Proposed Sale	182.40	1,482	270,317		Oct 22 02:10 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Option Exercise	103.57	227	23,510	38,344	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Sale	188.13	227	42,706	38,117	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	Officer	Sep 26 '25	Proposed Sale	188.13	227	42,706		Sep 26 04:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Option Exercise	103.57	28,288	2,929,788	66,405	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Option Exercise	103.57	175	18,125	38,292	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Sale	187.12	28,288	5,293,313	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Sale	187.02	175	32,729	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	Officer	Sep 24 '25	Proposed Sale	187.02	175	32,729		Sep 24 04:10 PM
PREVOZNIK MICHAEL E	Officer	Sep 23 '25	Proposed Sale	187.12	28,288	5,293,313		Sep 23 04:14 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 21 '25	Sale	185.00	1,975	365,375	15,269	Aug 25 04:27 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Option Exercise	112.17	4,532	508,354	21,776	Aug 21 04:34 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Sale	183.00	4,532	829,356	17,244	Aug 21 04:34 PM
Plewman Patrick	Officer	Aug 21 '25	Proposed Sale	185.00	1,975	365,375		Aug 21 12:10 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 15 '25	Sale	180.00	1,975	355,500	17,244	Aug 19 04:47 PM
Plewman Patrick	Director	Aug 19 '25	Proposed Sale	183.00	4,532	829,356		Aug 19 04:09 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	72	12,960		Aug 15 05:29 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	1,903	342,540		Aug 15 05:22 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Option Exercise	86.63	3,560	308,403	24,745	Aug 08 04:40 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Sale	175.00	5,535	968,625	19,219	Aug 08 04:40 PM
Plewman Patrick	Officer	Aug 06 '25	Proposed Sale	175.00	5,535	968,625		Aug 06 01:54 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 30 '25	Option Exercise	102.77	8,269	849,764	15,884	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 30 '25	Sale	167.40	8,269	1,384,231	10,660	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jul 31 '25	Sale	170.00	2,210	375,700	8,450	Aug 01 04:37 PM
KUPPUSAMY KARTHIK	Officer	Jul 31 '25	Proposed Sale	170.00	2,210	375,700		Jul 31 02:27 PM
KUPPUSAMY KARTHIK	Officer	Jul 30 '25	Proposed Sale	167.40	8,269	1,384,231		Jul 30 03:59 PM
DELANEY MARK E	SVP & Chief Commercial Officer	May 12 '25	Sale	175.72	874	153,579	8,372	May 14 05:12 PM
DELANEY MARK E	SVP & Chief Commercial Officer	May 13 '25	Sale	175.31	874	153,221	7,498	May 14 05:12 PM
DELANEY MARK E	Officer	May 13 '25	Proposed Sale	175.31	874	153,221		May 13 09:59 AM
DELANEY MARK E	Officer	May 12 '25	Proposed Sale	175.72	874	153,579		May 12 10:01 AM
Davis J. E.	CEO and President	Apr 02 '25	Sale	168.46	39,191	6,602,074	127,623	Apr 04 08:29 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 02 '25	Sale	170.00	2,555	434,350	10,575	Apr 04 08:26 PM
Davis J. E.	Officer	Apr 02 '25	Proposed Sale	170.00	39,191	6,662,470		Apr 02 10:20 AM
KUPPUSAMY KARTHIK	Officer	Apr 02 '25	Proposed Sale	170.00	2,555	434,350		Apr 02 09:50 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 17 '25	Sale	170.00	4,643	789,310	38,117	Mar 19 09:00 PM
PREVOZNIK MICHAEL E	Officer	Mar 17 '25	Proposed Sale	170.00	4,643	789,310		Mar 17 10:15 AM
Doherty Catherine T.	EVP, Regional Businesses	Mar 05 '25	Sale	174.13	5,370	935,078	68,068	Mar 07 07:23 PM
Doherty Catherine T.	EVP, Regional Businesses	Mar 04 '25	Sale	175.79	716	125,866	68,068	Mar 05 04:38 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 04 '25	Sale	175.79	592	104,068	38,117	Mar 05 04:35 PM
Doherty Catherine T.	Officer	Mar 05 '25	Proposed Sale	174.13	5,370	935,078		Mar 05 09:59 AM
PREVOZNIK MICHAEL E	Officer	Mar 04 '25	Proposed Sale	175.79	592	104,068		Mar 04 10:20 AM
Doherty Catherine T.	Officer	Mar 04 '25	Proposed Sale	175.79	716	125,866		Mar 04 09:58 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 27 '25	Sale	172.61	528	91,138	39,031	Feb 28 04:38 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 27 '25	Sale	172.61	824	142,231	69,178	Feb 28 04:35 PM
Doherty Catherine T.	Officer	Feb 27 '25	Proposed Sale	172.61	824	142,231		Feb 27 10:52 AM
PREVOZNIK MICHAEL E	Officer	Feb 27 '25	Proposed Sale	172.61	528	91,138		Feb 27 10:41 AM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 20 '25	Sale	170.99	604	103,278	39,845	Feb 21 04:44 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 19 '25	Sale	169.71	320	54,307	18,082	Feb 21 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 20 '25	Sale	170.99	899	153,720	70,457	Feb 21 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 19 '25	Sale	169.71	535	90,795	71,356	Feb 21 04:41 PM
PREVOZNIK MICHAEL E	Officer	Feb 20 '25	Proposed Sale	170.99	604	103,278		Feb 20 10:01 AM
Doherty Catherine T.	Officer	Feb 20 '25	Proposed Sale	170.99	899	153,720		Feb 20 09:56 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics, Inc

Upgrade your FINVIZ experience